0

Close
 
Upcoming Allied Market Research
2023
Collagen Fiber Suture Market

Collagen Fiber Suture Market

by Drug Type (Monofilament, Multifilament) and by Application (Cardiovascular Surgeries, General Surgeries, Gynecological Surgeries, Orthopedic Surgeries, Ophthalmic Surgeries, Other Surgeries): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A03246
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Collagen Fiber Suture Market

Request Now !

Collagen fiber suture is a medical tool to stich the cutaneous wound and close the surgical incision. It is used to stich internal organs, skin, blood vessels, and all other tissues of the human body after surgery.

Surge in surgical procedures due to increased incidences of various chronic diseases and technological advancements in collagen fiber suture products drive the market. However, lack of proper sterilization system in healthcare organizations and unfavorable taxation policies are expected to hinder the collagen fiber sutures market growth. Opportunities in the emerging economies of Asia-Pacific and LAMEA due to availability of large patient pools provide growth prospects for the market.

The report segments the global collagen fiber suture market based on product type, application, and region. Based on product type, the market is bifurcated into monofilament and multifilament. Based on application, it is divided into cardiovascular, general, gynecological, orthopedic, ophthalmic, and other surgeries. By geography, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Key players operating in the market include Arthrex, Inc., Ethicon Inc., Stryker Corporation, Gore Medical, DSM Biomedical, DemeTECH Corporation, Mimedx Group, Inc., and Collagen Matrix, Inc.

Key Benefits

  • The study provides an in-depth analysis of the global market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Competitive intelligence highlights the business practices followed by leading players across various regions.
  • Comprehensive analysis of all geographic regions are provided that elucidates the prevailing opportunities in these regions.
  • Key market players within the market are profiled in the report and their strategies are analyzed thoroughly, which helps understand the competitive outlook of the global market.
  • Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

 Collagen Fiber Suture Market Report Highlights

Aspects Details
By Drug Type
  • Monofilament
  • Multifilament
By Application
  • Cardiovascular Surgeries
  • General Surgeries
  • Gynecological Surgeries
  • Orthopedic Surgeries
  • Ophthalmic Surgeries
  • Other Surgeries
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Ethicon Inc., Collagen Matrix, Inc., DemeTECH Corporation, Mimedx Group, Inc., Gore Medical, Stryker Corporation, Unisur Lifecare Private Limited, Sutumed, DSM Biomedical, Arthrex, Inc.
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: COLLAGEN FIBER SUTURE MARKET, BY DRUG TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Drug Type

    • 4.2. Monofilament

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Multifilament

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: COLLAGEN FIBER SUTURE MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Cardiovascular Surgeries

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. General Surgeries

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Gynecological Surgeries

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Orthopedic Surgeries

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Ophthalmic Surgeries

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Other Surgeries

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

  • CHAPTER 6: COLLAGEN FIBER SUTURE MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Drug Type

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Collagen Fiber Suture Market

        • 6.2.5.1. Market Size and Forecast, By Drug Type
        • 6.2.5.2. Market Size and Forecast, By Application

      • 6.2.6. Canada Collagen Fiber Suture Market

        • 6.2.6.1. Market Size and Forecast, By Drug Type
        • 6.2.6.2. Market Size and Forecast, By Application

      • 6.2.7. Mexico Collagen Fiber Suture Market

        • 6.2.7.1. Market Size and Forecast, By Drug Type
        • 6.2.7.2. Market Size and Forecast, By Application

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Drug Type

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Collagen Fiber Suture Market

        • 6.3.5.1. Market Size and Forecast, By Drug Type
        • 6.3.5.2. Market Size and Forecast, By Application

      • 6.3.6. Germany Collagen Fiber Suture Market

        • 6.3.6.1. Market Size and Forecast, By Drug Type
        • 6.3.6.2. Market Size and Forecast, By Application

      • 6.3.7. Italy Collagen Fiber Suture Market

        • 6.3.7.1. Market Size and Forecast, By Drug Type
        • 6.3.7.2. Market Size and Forecast, By Application

      • 6.3.8. Spain Collagen Fiber Suture Market

        • 6.3.8.1. Market Size and Forecast, By Drug Type
        • 6.3.8.2. Market Size and Forecast, By Application

      • 6.3.9. UK Collagen Fiber Suture Market

        • 6.3.9.1. Market Size and Forecast, By Drug Type
        • 6.3.9.2. Market Size and Forecast, By Application

      • 6.3.10. Russia Collagen Fiber Suture Market

        • 6.3.10.1. Market Size and Forecast, By Drug Type
        • 6.3.10.2. Market Size and Forecast, By Application

      • 6.3.11. Rest Of Europe Collagen Fiber Suture Market

        • 6.3.11.1. Market Size and Forecast, By Drug Type
        • 6.3.11.2. Market Size and Forecast, By Application

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Drug Type

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Collagen Fiber Suture Market

        • 6.4.5.1. Market Size and Forecast, By Drug Type
        • 6.4.5.2. Market Size and Forecast, By Application

      • 6.4.6. Japan Collagen Fiber Suture Market

        • 6.4.6.1. Market Size and Forecast, By Drug Type
        • 6.4.6.2. Market Size and Forecast, By Application

      • 6.4.7. India Collagen Fiber Suture Market

        • 6.4.7.1. Market Size and Forecast, By Drug Type
        • 6.4.7.2. Market Size and Forecast, By Application

      • 6.4.8. South Korea Collagen Fiber Suture Market

        • 6.4.8.1. Market Size and Forecast, By Drug Type
        • 6.4.8.2. Market Size and Forecast, By Application

      • 6.4.9. Australia Collagen Fiber Suture Market

        • 6.4.9.1. Market Size and Forecast, By Drug Type
        • 6.4.9.2. Market Size and Forecast, By Application

      • 6.4.10. Thailand Collagen Fiber Suture Market

        • 6.4.10.1. Market Size and Forecast, By Drug Type
        • 6.4.10.2. Market Size and Forecast, By Application

      • 6.4.11. Malaysia Collagen Fiber Suture Market

        • 6.4.11.1. Market Size and Forecast, By Drug Type
        • 6.4.11.2. Market Size and Forecast, By Application

      • 6.4.12. Indonesia Collagen Fiber Suture Market

        • 6.4.12.1. Market Size and Forecast, By Drug Type
        • 6.4.12.2. Market Size and Forecast, By Application

      • 6.4.13. Rest of Asia Pacific Collagen Fiber Suture Market

        • 6.4.13.1. Market Size and Forecast, By Drug Type
        • 6.4.13.2. Market Size and Forecast, By Application

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Drug Type

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Collagen Fiber Suture Market

        • 6.5.5.1. Market Size and Forecast, By Drug Type
        • 6.5.5.2. Market Size and Forecast, By Application

      • 6.5.6. South Africa Collagen Fiber Suture Market

        • 6.5.6.1. Market Size and Forecast, By Drug Type
        • 6.5.6.2. Market Size and Forecast, By Application

      • 6.5.7. Saudi Arabia Collagen Fiber Suture Market

        • 6.5.7.1. Market Size and Forecast, By Drug Type
        • 6.5.7.2. Market Size and Forecast, By Application

      • 6.5.8. UAE Collagen Fiber Suture Market

        • 6.5.8.1. Market Size and Forecast, By Drug Type
        • 6.5.8.2. Market Size and Forecast, By Application

      • 6.5.9. Argentina Collagen Fiber Suture Market

        • 6.5.9.1. Market Size and Forecast, By Drug Type
        • 6.5.9.2. Market Size and Forecast, By Application

      • 6.5.10. Rest of LAMEA Collagen Fiber Suture Market

        • 6.5.10.1. Market Size and Forecast, By Drug Type
        • 6.5.10.2. Market Size and Forecast, By Application

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Arthrex, Inc.

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Ethicon Inc.

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Stryker Corporation

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Gore Medical

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. DSM Biomedical

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. DemeTECH Corporation

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Mimedx Group, Inc.

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Collagen Matrix, Inc.

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Sutumed

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Unisur Lifecare Private Limited

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL COLLAGEN FIBER SUTURE MARKET, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL COLLAGEN FIBER SUTURE MARKET FOR MONOFILAMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL COLLAGEN FIBER SUTURE MARKET FOR MULTIFILAMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL COLLAGEN FIBER SUTURE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL COLLAGEN FIBER SUTURE MARKET FOR CARDIOVASCULAR SURGERIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL COLLAGEN FIBER SUTURE MARKET FOR GENERAL SURGERIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL COLLAGEN FIBER SUTURE MARKET FOR GYNECOLOGICAL SURGERIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL COLLAGEN FIBER SUTURE MARKET FOR ORTHOPEDIC SURGERIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL COLLAGEN FIBER SUTURE MARKET FOR OPHTHALMIC SURGERIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL COLLAGEN FIBER SUTURE MARKET FOR OTHER SURGERIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL COLLAGEN FIBER SUTURE MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA COLLAGEN FIBER SUTURE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 15. U.S. COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 16. U.S. COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 17. CANADA COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 18. CANADA COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. MEXICO COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 20. MEXICO COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 21. EUROPE COLLAGEN FIBER SUTURE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. EUROPE COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 23. EUROPE COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 24. FRANCE COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 25. FRANCE COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. GERMANY COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 27. GERMANY COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. ITALY COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 29. ITALY COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. SPAIN COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 31. SPAIN COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. UK COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 33. UK COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 34. RUSSIA COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 35. RUSSIA COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. REST OF EUROPE COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 37. REST OF EUROPE COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. ASIA-PACIFIC COLLAGEN FIBER SUTURE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 39. ASIA-PACIFIC COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 40. ASIA-PACIFIC COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. CHINA COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 42. CHINA COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. JAPAN COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 44. JAPAN COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. INDIA COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 46. INDIA COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 47. SOUTH KOREA COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 48. SOUTH KOREA COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 49. AUSTRALIA COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 50. AUSTRALIA COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. THAILAND COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 52. THAILAND COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 53. MALAYSIA COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 54. MALAYSIA COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. INDONESIA COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 56. INDONESIA COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 58. REST OF ASIA PACIFIC COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 59. LAMEA COLLAGEN FIBER SUTURE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 60. LAMEA COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 61. LAMEA COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. BRAZIL COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 63. BRAZIL COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH AFRICA COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH AFRICA COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. SAUDI ARABIA COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 67. SAUDI ARABIA COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. UAE COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 69. UAE COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. ARGENTINA COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 71. ARGENTINA COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 72. REST OF LAMEA COLLAGEN FIBER SUTURE, BY DRUG TYPE, 2022-2032 ($MILLION)
  • TABLE 73. REST OF LAMEA COLLAGEN FIBER SUTURE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 74. ARTHREX, INC.: KEY EXECUTIVES
  • TABLE 75. ARTHREX, INC.: COMPANY SNAPSHOT
  • TABLE 76. ARTHREX, INC.: OPERATING SEGMENTS
  • TABLE 77. ARTHREX, INC.: PRODUCT PORTFOLIO
  • TABLE 78. ARTHREX, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 79. ETHICON INC.: KEY EXECUTIVES
  • TABLE 80. ETHICON INC.: COMPANY SNAPSHOT
  • TABLE 81. ETHICON INC.: OPERATING SEGMENTS
  • TABLE 82. ETHICON INC.: PRODUCT PORTFOLIO
  • TABLE 83. ETHICON INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 84. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 85. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 86. STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 87. STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 88. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 89. GORE MEDICAL: KEY EXECUTIVES
  • TABLE 90. GORE MEDICAL: COMPANY SNAPSHOT
  • TABLE 91. GORE MEDICAL: OPERATING SEGMENTS
  • TABLE 92. GORE MEDICAL: PRODUCT PORTFOLIO
  • TABLE 93. GORE MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 94. DSM BIOMEDICAL: KEY EXECUTIVES
  • TABLE 95. DSM BIOMEDICAL: COMPANY SNAPSHOT
  • TABLE 96. DSM BIOMEDICAL: OPERATING SEGMENTS
  • TABLE 97. DSM BIOMEDICAL: PRODUCT PORTFOLIO
  • TABLE 98. DSM BIOMEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 99. DEMETECH CORPORATION: KEY EXECUTIVES
  • TABLE 100. DEMETECH CORPORATION: COMPANY SNAPSHOT
  • TABLE 101. DEMETECH CORPORATION: OPERATING SEGMENTS
  • TABLE 102. DEMETECH CORPORATION: PRODUCT PORTFOLIO
  • TABLE 103. DEMETECH CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 104. MIMEDX GROUP, INC.: KEY EXECUTIVES
  • TABLE 105. MIMEDX GROUP, INC.: COMPANY SNAPSHOT
  • TABLE 106. MIMEDX GROUP, INC.: OPERATING SEGMENTS
  • TABLE 107. MIMEDX GROUP, INC.: PRODUCT PORTFOLIO
  • TABLE 108. MIMEDX GROUP, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 109. COLLAGEN MATRIX, INC.: KEY EXECUTIVES
  • TABLE 110. COLLAGEN MATRIX, INC.: COMPANY SNAPSHOT
  • TABLE 111. COLLAGEN MATRIX, INC.: OPERATING SEGMENTS
  • TABLE 112. COLLAGEN MATRIX, INC.: PRODUCT PORTFOLIO
  • TABLE 113. COLLAGEN MATRIX, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. SUTUMED: KEY EXECUTIVES
  • TABLE 115. SUTUMED: COMPANY SNAPSHOT
  • TABLE 116. SUTUMED: OPERATING SEGMENTS
  • TABLE 117. SUTUMED: PRODUCT PORTFOLIO
  • TABLE 118. SUTUMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. UNISUR LIFECARE PRIVATE LIMITED: KEY EXECUTIVES
  • TABLE 120. UNISUR LIFECARE PRIVATE LIMITED: COMPANY SNAPSHOT
  • TABLE 121. UNISUR LIFECARE PRIVATE LIMITED: OPERATING SEGMENTS
  • TABLE 122. UNISUR LIFECARE PRIVATE LIMITED: PRODUCT PORTFOLIO
  • TABLE 123. UNISUR LIFECARE PRIVATE LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL COLLAGEN FIBER SUTURE MARKET SEGMENTATION
  • FIGURE 2. GLOBAL COLLAGEN FIBER SUTURE MARKET
  • FIGURE 3. SEGMENTATION COLLAGEN FIBER SUTURE MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN COLLAGEN FIBER SUTURE MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCOLLAGEN FIBER SUTURE MARKET
  • FIGURE 11. COLLAGEN FIBER SUTURE MARKET SEGMENTATION, BY BY DRUG TYPE
  • FIGURE 12. COLLAGEN FIBER SUTURE MARKET FOR MONOFILAMENT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. COLLAGEN FIBER SUTURE MARKET FOR MULTIFILAMENT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. COLLAGEN FIBER SUTURE MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 15. COLLAGEN FIBER SUTURE MARKET FOR CARDIOVASCULAR SURGERIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. COLLAGEN FIBER SUTURE MARKET FOR GENERAL SURGERIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. COLLAGEN FIBER SUTURE MARKET FOR GYNECOLOGICAL SURGERIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. COLLAGEN FIBER SUTURE MARKET FOR ORTHOPEDIC SURGERIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. COLLAGEN FIBER SUTURE MARKET FOR OPHTHALMIC SURGERIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. COLLAGEN FIBER SUTURE MARKET FOR OTHER SURGERIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 25. COMPETITIVE DASHBOARD
  • FIGURE 26. COMPETITIVE HEATMAP: COLLAGEN FIBER SUTURE MARKET
  • FIGURE 27. Top player positioning, 2022
  • FIGURE 28. ARTHREX, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 29. ARTHREX, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 30. ARTHREX, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 31. ETHICON INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 32. ETHICON INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 33. ETHICON INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 34. STRYKER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 35. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 36. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 37. GORE MEDICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. GORE MEDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. GORE MEDICAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. DSM BIOMEDICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. DSM BIOMEDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. DSM BIOMEDICAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. DEMETECH CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. DEMETECH CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. DEMETECH CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. MIMEDX GROUP, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. MIMEDX GROUP, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. MIMEDX GROUP, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. COLLAGEN MATRIX, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. COLLAGEN MATRIX, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. COLLAGEN MATRIX, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. SUTUMED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. SUTUMED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. SUTUMED: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. UNISUR LIFECARE PRIVATE LIMITED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. UNISUR LIFECARE PRIVATE LIMITED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. UNISUR LIFECARE PRIVATE LIMITED: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Collagen Fiber Suture Market

Start reading.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers